Pharmacological and genetic activation of cAMP synthesis disrupts cholesterol utilization in Mycobacterium tuberculosis.

MLA

Kaley M Wilburn, et al. “Pharmacological and Genetic Activation of CAMP Synthesis Disrupts Cholesterol Utilization in Mycobacterium Tuberculosis.” PLoS Pathogens, vol. 18, no. 2, Feb. 2022, p. e1009862. EBSCOhost, https://doi.org/10.1371/journal.ppat.1009862.

APA

Kaley M Wilburn, Christine R Montague, Bo Qin, Ashley K Woods, Melissa S Love, Case W McNamara, Peter G Schultz, Teresa L Southard, Lu Huang, H Michael Petrassi, & Brian C VanderVen. (2022). Pharmacological and genetic activation of cAMP synthesis disrupts cholesterol utilization in Mycobacterium tuberculosis. PLoS Pathogens, 18(2), e1009862. https://doi.org/10.1371/journal.ppat.1009862

Chicago

Kaley M Wilburn, Christine R Montague, Bo Qin, Ashley K Woods, Melissa S Love, Case W McNamara, Peter G Schultz, et al. 2022. “Pharmacological and Genetic Activation of CAMP Synthesis Disrupts Cholesterol Utilization in Mycobacterium Tuberculosis.” PLoS Pathogens 18 (2): e1009862. doi:10.1371/journal.ppat.1009862.